This hub covers epilepsy devices and neuromodulation like VNS, RNS, and DBS, which are treatments that can reduce seizures when meds aren’t enough. Plain-language research summaries plus real-life pros/cons.
Some are used more often in adults, but pediatric use depends on the device, the case, and specialist guidance.
Often gradually. Improvement can build over months as settings are optimized.
Sometimes medication can be reduced, but many people still use meds alongside a device.
Sometimes yes, with device-specific rules. Always check the exact device guidelines first.
Researchers studied brain MRI scans of 139 children with specific genetic types of epilepsy linked to four genes: SCN1A, SCN2A, SCN3A, and SCN8A.
This study looked at febrile seizures (FSs) in young children, specifically those aged 6 months to 3 years, who were treated at a pediatric hospital in Shanghai between April 2021 and March 2023.
Researchers studied the safety of deep brain stimulation (DBS), a surgical treatment used for conditions like epilepsy, by comparing it to other common elective surgeries.
Researchers studied the effects of vagal nerve stimulation (VNS) on children with drug-refractory epilepsy (DRE) in South Africa.
This study looked at how well a new type of EEG monitoring works for people with severe forms of epilepsy, specifically developmental and epileptic encephalopathies (DEEs).
This study looked at how a new computer-based tool, called the Functional/Dissociative Seizures Likelihood Score (FSLS), can help doctors diagnose functional or dissociative seizures (FDS).
Researchers studied juvenile absence epilepsy (JAE) to understand how it affects the brain and cognitive abilities.
This study looked at the outcomes of surgeries for vagus nerve stimulation (VNS) in children with drug-resistant epilepsy.
Researchers studied the long-term effects of vagus nerve stimulation (VNS) on people with Dravet syndrome, a severe form of epilepsy.